Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline
LA Korde, MR Somerfield, LA Carey… - Journal of Clinical …, 2021 - ascopubs.org
… of breast cancer has evolved in recent decades, it has become clear that optimal therapy for
breast cancer … The purpose of this guideline is to develop recommendations concerning the …
breast cancer … The purpose of this guideline is to develop recommendations concerning the …
Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO guideline
M Brackstone, FG Baldassarre, FE Perera… - Journal of Clinical …, 2021 - ascopubs.org
… For women with early-stage breast cancer without nodal metastases… ASCO guideline 9,10
for surgical interventions. For radiotherapy interventions, we included the Early Breast Cancer …
for surgical interventions. For radiotherapy interventions, we included the Early Breast Cancer …
Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO guideline update
N Denduluri, MR Somerfield… - Journal of Clinical …, 2021 - ascopubs.org
… the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal
… chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast …
… chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast …
Clinical practice guidelines in breast cancer
NK Tyagi, S Dhesy-Thind - Current Oncology, 2018 - mdpi.com
… The asco guideline on ofs was a focused guideline update dedicated to the topic24… asco
guideline was a focused update to a 2014 guideline on slnb in early-stage bca25. The guideline …
guideline was a focused update to a 2014 guideline on slnb in early-stage bca25. The guideline …
Management of male breast cancer: ASCO guideline
MJ Hassett, MR Somerfield, ER Baker… - Journal of Clinical …, 2020 - ascopubs.org
… male breast cancer and chose to develop the guideline using a … Panel identified aspects of
breast cancer care for which … experts from ASCO’s Breast Cancer Guideline Advisory Group. …
breast cancer care for which … experts from ASCO’s Breast Cancer Guideline Advisory Group. …
Biomarkers for systemic therapy in metastatic breast cancer: ASCO guideline update
… ASCO guideline panel members to identify signals. This systematic review-based guideline
product was developed by an ASCO … patient representative and an ASCO staff member with …
product was developed by an ASCO … patient representative and an ASCO staff member with …
Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update
F Andre, N Ismaila, KH Allison, WE Barlow… - Journal of Clinical …, 2022 - ascopubs.org
… Since the 2016 guidelines on biomarkers for breast cancer, several … This guideline update
provides evidence-based … with early-stage breast cancer with known estrogen receptor (ER) …
provides evidence-based … with early-stage breast cancer with known estrogen receptor (ER) …
Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update
N Denduluri, M Chavez-MacGregor, ML Telli… - Journal of Clinical …, 2018 - ascopubs.org
… these signals, the ASCO Breast Cancer Advisory Group ranked updating the adjuvant therapy
guideline adaptation among its highest priorities. To that end, ASCO convened an Expert …
guideline adaptation among its highest priorities. To that end, ASCO convened an Expert …
Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update
K Visvanathan, CJ Fabian, E Bantug… - Journal of clinical …, 2019 - ascopubs.org
… ASCO first published clinical practice recommendations for the use of pharmacologic …
breast cancer risk reduction in 1999. ASCO updated these breast cancer risk reduction guideline …
breast cancer risk reduction in 1999. ASCO updated these breast cancer risk reduction guideline …
Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update
…, KA Gelmon, SH Giordano, CA Hudis… - Journal of Clinical …, 2019 - ascopubs.org
Purpose To update the ASCO clinical practice guideline on adjuvant endocrine therapy
based on emerging data about the optimal duration of aromatase inhibitor (AI) treatment. …
based on emerging data about the optimal duration of aromatase inhibitor (AI) treatment. …
相关搜索
- asco clinical practice guideline breast cancer
- clinical guidelines breast cancer treatment
- practice guideline breast cancer risk reduction
- male breast cancer
- metastatic breast cancer
- adjuvant endocrine therapy breast cancer
- targeted therapy breast cancer
- early stage breast cancer
- adjuvant chemotherapy breast cancer
- neoadjuvant chemotherapy breast cancer
- neoadjuvant therapy breast cancer
- pharmacologic interventions breast cancer risk reduction
- breast cancer patients
- hormone receptor breast cancer
- meta analysis breast cancer
- american society breast cancer